TEVA Trading Analysis - 09/16/2026 04:18 PM — TRU-SENTIMENT

News Headlines & Context:

Recent news headlines for TEVA include:

• Teva Pharmaceutical Industries Ltd. (TEVA) announced a settlement with the US Department of Justice regarding allegations of misbranding and improper marketing of certain medications.
• TEVA reported better-than-expected quarterly earnings, driven by strong sales of its generic and specialty medications.
• The company announced a collaboration with a leading research institution to develop new treatments for a rare neurological disorder.

These headlines suggest that TEVA is actively addressing regulatory concerns, delivering strong financial performance, and investing in research and development. This context may support a bullish technical and sentiment analysis.

Fundamental Analysis:

Based on the provided fundamentals data:

• Revenue: $14,104,000,000
• Trailing EPS: $0.60
• Trailing P/E: 65.42
• Price-to-Book: 11.77
• Debt-to-Equity: 4.14
• Return on Equity (ROE): 9.14%
• Gross Margin: 64.41%
• Operating Margin: 11.36%
• Profit Margin: 5.03%

The fundamentals indicate:

• High P/E ratio, suggesting potential overvaluation.
• Strong ROE and profit margins.
• Significant debt-to-equity ratio, which could be a concern.

These factors suggest a mixed fundamental picture, with both strengths and weaknesses.

Current Market Position:

Current price: $38.53

Recent price action: The stock has shown an uptrend, with the current price near the upper end of the 30-day range.

Intraday momentum: The minute bars indicate a slight increase in price with moderate volume.

Technical Analysis:

SMA trends:

• 5-day SMA: $37.99
• 20-day SMA: $37.24
• 50-day SMA: $35.12

The stock is above all three SMAs, indicating a bullish trend.

RSI (14): $53.37, which is neutral.

MACD: $0.72 (above signal line), indicating a bullish signal.

Bollinger Bands: The stock is near the upper band, suggesting a potential overbought condition.

30-day high/low: $39.52 / $33.89, with the stock currently near the upper end of this range.

True Sentiment Analysis (Delta 40-60 Options):

Overall sentiment: Bullish

Call vs. Put dollar volume: $4246534 (calls) vs. $47244 (puts), indicating strong bullish conviction.

Pure directional positioning suggests near-term expectations are bullish.

Key Price Levels:

• Support: $35.00, $36.00
• Resistance: $39.00, $40.00

25-Day Price Forecast:

TEVA is projected for $39.50 to $41.20

Based on current trends, momentum, and indicators, the stock is expected to continue its upward trajectory, with potential resistance at $40.00.

Defined Risk Strategy Recommendations:

Based on the price forecast ($39.50 to $41.20), consider the following strategies:

• Bull Call Spread: Buy $38.00 call, sell $41.00 call (expiration: 2026-10-16)
• Iron Condor: Sell $39.00 call, buy $42.00 call, sell $36.00 put, buy $33.00 put (expiration: 2026-10-16)

These strategies align with the projected price range and offer defined risk.

Risk Factors:

• Technical warning signs: Overbought condition near $40.00.
• Sentiment divergences: None apparent.
• Volatility: ATR $1.22, indicating moderate volatility.

Summary & Conviction Level:

Overall bias: Bullish

Conviction level: High

One-line trade idea: TEVA appears poised for continued upside, driven by bullish technical and sentiment trends.